Don’t miss outtag icon
Are you tracking AI visibility, or guessing? Get clarity with Similarweb’s AEO ToolkitTry it nowbanner icon
Medical Center "Reprolife"

December 2025

  • Home
  • Medical Center "Reprolife"

Medical Center "Reprolife" Market Share Analysis for December 2025

Медицинская эмбриология: методы изучения эмбрионов человека для лечения бесплодия. ✔ Специалисты репродуктологи. ✔ Консультация эмбриолога в клинике Reprolife в Киеве.
Year Founded2016
Employees51 - 200
Annual Revenue--
reprolife.ua
Medical Center "Reprolife"
Medical Center "Reprolife" (including company regionals)
  • reprolife.ua
    reprolife.ua
See more website traffic and engagement information

Total visits to Medical Center "Reprolife"'s top domains

Understand Medical Center "Reprolife" market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

Avg. visit duration in Medical Center "Reprolife"'s top domains

Analyze Medical Center "Reprolife" engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

Avg. pageviews on Medical Center "Reprolife"'s top domains

See how Medical Center "Reprolife" keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

Want to gain deeper traffic insights?

Filter 20.3M+ online businesses. Discover new leads when their traffic spikes, when they start or stop using technologies, or when they get positive press.



Top technologies used by Medical Center "Reprolife"

These are the website technologies, by industry, used by Medical Center "Reprolife" top domains

Advertising (7)

Google Adsense

Google Adsense

Widget (5)

Twemoji

Twemoji

Conversion & Analytics (3)

Google Analytics

Google Analytics

Social (3)

Instagram

Instagram

More Technologies

9

See all

Ready to discover high quality prospects?

Identify what technologies a website uses to craft the perfect sales pitch, and shorten the sales cycle with the Similarweb Sales Intelligence Solution.